EcoDrugPlus

Tubulin Beta-4b Chain-Like

Ensembl ID : ENSIPUG00000016684
Gene Symbol: LOC108262309
3 Cross references
15 Possible Orthologues:

Tubulin Beta-4b Chain-Like

Ensembl ID : ENSIPUG00000016154
Gene Symbol: LOC108255360
2 Cross references
15 Possible Orthologues:

Tubulin Beta-4b Chain-Like

Ensembl ID : ENSIPUG00000016454
Gene Symbol: LOC108255957
2 Cross references
15 Possible Orthologues:

Tubulin, Alpha 8 Like 2

Ensembl ID : ENSIPUG00000005043
Gene Symbol: TUBA8L2
3 Cross references
195 Possible Orthologues:

Tubulin, Beta 1 Class Vi

Ensembl ID : ENSIPUG00000010950
Gene Symbol: TUBB1
3 Cross references
184 Possible Orthologues:

Tubulin, Beta 5

Ensembl ID : ENSIPUG00000005053
Gene Symbol: TUBB5
3 Cross references
221 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSIPUG00000021439
Gene Symbol: TP53
2 Cross references
160 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSIPUG00000011963
Gene Symbol: TYR
3 Cross references
198 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSIPUG00000002526
Gene Symbol: TYR
4 Cross references
202 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSIPUG00000005463
Gene Symbol: TH
4 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSIPUG00000013222
Gene Symbol: TYK2
3 Cross references
195 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin-Like And Egf-Like Domains 1

Ensembl ID : ENSIPUG00000005642
Gene Symbol: TIE1
3 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).